BioNTech (BNTX)

• Market cap: $27.4B
• 1 day: -0.76%
• 5 days: -0.16%
• 1 month: -7.62%
• 3 months: 6.14%
• 6 months: 4.03%
• Year to date: 12.74%
• 1 year: -4.38%
• 5 years: -0.02%
• 10 years: 665.52%
• Sector: Healthcare
• Industry: Biotechnology

About: BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Employees: 6,772